Cerus | CERS - Operating Expenses

Stock Price
2.08
Daily Change
0.08 4.00%
Monthly
15.56%
Yearly
61.24%
Q2 Forecast
2.03

Cerus reported $34.78M in Operating Expenses for its fiscal quarter ending in December of 2024.





Operating Expenses Change Date
Cerus USD 34.78M 2.98M Dec/2024
GRIFOLS EUR 1.71B 193M Dec/2025
Haemonetics USD 134.99M 1.26M Dec/2025
Neogen USD 214.5M 15.57M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Plus Therapeutics USD 7.11M 1.23M Dec/2025
Quidel USD 760.9M 1.28B Dec/2025
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 68.74M 1.55M Dec/2025
Terumo JPY 252.74B 22.88B Dec/2025
Utah Medical Products USD 6.6M 354K Dec/2025